Review Article
Anticancer Activity of Green Tea Polyphenols in Prostate Gland
Table 4
Studies on the effect of GTCs administration to TRAMP mice and humans with PCa.
| Experimental groups | GTCs dose g/100 mL [oral administration] | Formulation (%) | PCa phases age-dependent (weeks) | PCa inhibition (%) | References |
| TRAMP mice | 0.06 | GTCsa | Start 5; end 12 | 83 |
[61] | EGCG (93) | 0.1 | GTCsb: | Start 8; end 32 | 42 |
[53] | EGCG (62) | ECG (24) | EGC (5) | EC (6) | 0.1 | GTCsb: | | |
[62] | EGCG (62) | Start 6; end 38 | ~50 | ECG (24) | EGC (5) | Start 18; end 24 | ~20 | EC (6) | 0.3 | GTCsc: | Start 8; end 24 | 80 |
[19] | EGC (5.5), | EC (12.2) | EGCG (51.9) | ECG (6.1) |
| | GTCs dose mg/day [oral administration] | GTCs providers | PCa phases | Percentage (%) of PCa inhibition | References |
| HUMANS | 500 | Sabinsa Corporation | CRPC | No effect | [63] | 6000 | Unilever | CRPC | No effect | [64] | 1300 | Polyphenon E Matsui Norin, | CRPC | Mild effect | [86] | 600 | Polyphenon E Matsui Norin | HGPIN | 33 | [65] | 800 | Polyphenon E Matsui Norin | CRPC | No effect | [85] |
|
|
GTCsa: Roche, GTCsb: natural resources and products, GTCsc: isolated by the investigators; CRPC (castration resistant prostate cancer), HGPIN (high grade prostatic intraepithelial neoplasia).
|